Arabinoxylan rice bran (MGN-3/Biobran) has been shown to be a potent biological response modifier (BRM) that activates different arms of the immune system, including dendritic cells (DCs), which prime CD4+ helper T-cell responses. The present study explores the ability of MGN-3-activated DCs to prime CD8+ T cells and examines the mechanisms underlying its effect. Human monocyte-derived DCs were treated with MGN-3 (20 and 40 fig/ml). Results indicate that treatment with MGN-3 caused DCs to prime higher granzyme B-expressing CD8+ T cells. Tumor lysate-pulsed MGN-3 DC also increased tumor cell killing compared to DC-stimulated CD8+ T cells. This was associated with: i) increased expression of DEC-205 in MGN-3-activated DCs in a dose-dependent manner; and ii) MGN-3 induced significant production of Type III interferon, IL29, but not Type I IFNs α and β. These results suggest that MGN-3 is a potent natural adjuvant that efficiently activates DCs and may therefore be useful for mounting an efficient immune response against infections and cancer.
El DinN BadrNoamanEGhoneumM. In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3/biobran on Ehrlich Carcinoma-bearing mice. Nutr Cancer2008; 60:235–44.
2.
NoamanEEl-DinNK BadrBibarsMAMossallamAA AbouGhoneumM. Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma. Cancer Letters2008; 268:348–59.
3.
BangMHVan RiepTThinhNT. Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: A three-year randomized clinical trial. Anticancer Res2010; 30:5145–51.
4.
PanalaVVergheseMBoatengJFieldRShackelfordLWalkerLT. A comparison of rice bran, corn oil and soybean oil against azoxymethane induced colon cancer in a Fisher 344 rat model. Int J Cancer Res2009; 5:25–35.
5.
MiyoshiNKoyamaYKatsunoYHayakawaSMitaTOhtaTKajiKIsemuraM. Apoptosis induction associated with cell cycle dysregulation by rice bran agglutinin. J Biochem2001; 130:799–805.
6.
KongCKLamWSChiuLCOoiVESunSSWongYS. A rice bran polyphenol, cycloartenyl ferulate, elicits apoptosis in human colorectal adenocarcinoma SW480 and sensitizes metastatic SW620 cells to TRAIL-induced apoptosis. Biochem Pharmacol2009; 77:1487–96.
7.
RaoASReddySGBabuPPReddyR. The antioxidant and antiproliferative activities of methanolic extracts from Njavara rice bran. BMC Complement Altera Med2010; 10:4.
8.
KunoTHiroseYHataK. Preventive effect of fermented brown rice and rice bran on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats. Int J Oncol2004; 25:1809–15.
9.
TomitaHKunoTYamadaY. Preventive effect of fermented brown rice and rice bran on N-methyl-N'-nitro-N-nitrosoguanidineinduced gastric carcinogenesis in rats. Oncol Rep2008; 19:11–5.
10.
LissoniPMissinaGBrivioF. Modulation of the anticancer immunity by natural agents inhibition of T regulatory lymphocyte generation by arabinoxylan in patients with locally limited ormetastatic solid tumors. Cancer Therapy2008; 6:1011–16.
11.
GhoneumM. Anti-HIV activity in vitro of MGN–3, an activated arabinoxylan from rice bran. Biochem Bioph Res Comm1998a; 243:25–9.
12.
GhoneumM. Enhancement of human natural killer cell activity by modified arabinoxylan from rice bran (MGN-3). Int J Immunother1998b; 14:89–99.
13.
GhoneumMJewettA. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Cancer Detect Prev2000; 24:314–24.
14.
GhoneumMAbediS. Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). J Pharmacy Pharmacol2004;56:1581–88.
15.
GhoneumMAgrawalS. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN–3/Biobran). Int J Immunopathol Pharmacol2011;24:941–48.
16.
CholujovaDJakubikovaJSedlakJ. BioBran augmented maturation of human monocyte-derived dendritic cells. Neoplasma2009; 56:89–95.
17.
ArugaA. [Dendritic cell-based cancer immunotherapy]. Nihon Rinsho2010; 68:1107–10.
18.
BrownGDGordonS. Immune recognition: A new receptor for β-glucans. Nature2001; 413:36–37.
TakeuchiOAkiraS. Pattern recognition receptors and inflammation. Cell2010; 140:805–20.
21.
IwasakiAMedzhitovR. Regulation of adaptive immunity by the innate immune system. Science2010; 327:291–95.
22.
GuoMGongSMaricSMisulovinZPackMMahnkeKNussenzweigMCSteinmanRM. A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells. Hum Immunol2000;61:729–38.
23.
MahnkeKGuoMLeeSSepulvedaHSwainSLNussenzweigMSteinmanRM. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol2000; 151:673–84.
24.
InabaKSwiggardWJInabaMMeltzerJMirzaASasagawaTNussenzweigMCSteinmanRM. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell Immunol1995; 163:148–56.
25.
KatoMNeilTKFearnleyDBMcLellanADUckovicSHartDN. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int Immunol2000; 12:1511–19.
26.
BonifazLBonnyayDMahnkeKRiveraMNussenzweigMCSteinmanRM. Efficient targeting of protein antigen to the dendritic cell receptor DEC–205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med2002; 196:1627–38.
27.
WolkKWitteKSabatR. Interleukin-28 and interleukin-29: Novel regulators of skin biology. J Interferon Cytokine Res2010; 30:617–28.
28.
LasfarAAbushahbaWBalanMCohen-SolalKA. Interferon lambda: A new sword in cancer immunotherapy. Clin Dev Immunol2011; 1–11.
29.
LiQKawamuraKTadaYShimadaHHiroshimaKTagawaM. Novel type III interferons produce anti-tumor effects through multiple functions. Front Biosci (Landmark Ed)2013; 18:909–18.
30.
AgrawalA. Mechanisms and implications of age-associated impaired innate interferon secretion by dendritic cells: A mini-review. Gerontology2013; 59:421–26.
MorrowMPYanJPankhongP. IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques. Mol Ther2010; 18:1714–23.
33.
BozzaccoLTrumpfhellerCSiegalFP. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci USA2007; 104:1289–94.
34.
JiangWSwiggardWJHeuflerCPengMMirzaASteinmanRMNussenzweigMC. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature1995; 375:151–55.
